Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 8
1971 19
1972 21
1973 14
1974 14
1975 8
1976 19
1977 13
1978 9
1979 14
1980 13
1981 13
1982 8
1983 14
1984 6
1985 9
1986 4
1987 6
1988 2
1989 9
1990 10
1991 20
1992 15
1993 21
1994 10
1995 14
1996 25
1997 20
1998 38
1999 35
2000 63
2001 48
2002 51
2003 85
2004 81
2005 83
2006 94
2007 88
2008 110
2009 122
2010 128
2011 112
2012 109
2013 165
2014 171
2015 139
2016 101
2017 83
2018 98
2019 92
2020 72
Text availability
Article attribute
Article type
Publication date

Search Results

2,325 results
Results by year
Filters applied: . Clear all
Page 1
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
Chande N, Patton PH, Tsoulis DJ, Thomas BS, MacDonald JK. Chande N, et al. Cochrane Database Syst Rev. 2015 Oct 30;(10):CD000067. doi: 10.1002/14651858.CD000067.pub3. Cochrane Database Syst Rev. 2015. PMID: 26517527 Review.
An updated meta-analysis was performed to evaluate the efficacy of these agents for the maintenance of remission in quiescent Crohn's disease. ...SELECTION CRITERIA: Randomized controlled trials of oral azathioprine or 6-mercaptopurine compared to placebo or …
An updated meta-analysis was performed to evaluate the efficacy of these agents for the maintenance of remission in quiescent Crohn's …
Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy.
Knyazev OV, Kagramanova AV, Fadeeva NA, Lishchinskaya AA, Boldyreva ON, Noskova KK, Gudkova RB, Konoplyannikov AG, Parfenov AI. Knyazev OV, et al. Ter Arkh. 2018 Feb 15;90(2):47-52. doi: 10.26442/terarkh201890247-52. Ter Arkh. 2018. PMID: 30701772
AIM: To evaluate the effectiveness of MSCs therapy in patients with CD receiving azathioprine (AZA). MATERIALS AND METHODS: The study included 34 patients with inflammatory (luminal) form of CD. ...The severity of the attack was assessed in points in accordance with the of …
AIM: To evaluate the effectiveness of MSCs therapy in patients with CD receiving azathioprine (AZA). MATERIALS AND METHODS: The study …
Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial.
López-Sanromán A, Vera-Mendoza I, Domènech E, Taxonera C, Vega Ruiz V, Marín-Jiménez I, Guardiola J, Castro L, Esteve M, Iglesias E, Ceballos D, Martínez-Montiel P, Gisbert JP, Mínguez M, Echarri A, Calvet X, Barrio J, Hinojosa J, Martín-Arranz MD, Márquez-Mosquera L, Bermejo F, Rimola J, Pons V, Nos P; Spanish GETECCU group [APPRECIA study]. López-Sanromán A, et al. J Crohns Colitis. 2017 Oct 27;11(11):1293-1301. doi: 10.1093/ecco-jcc/jjx051. J Crohns Colitis. 2017. PMID: 28402454 Clinical Trial.
BACKGROUND AND AIMS: Postoperative recurrence of Crohn's disease [POR-CD] is almost certain if no prophylaxis is administered. ...RESULTS: We recruited 91 patients [median age 35.0 years, disease duration 6.0 years, 23.8% smokers, 7.1% previous resections]. . …
BACKGROUND AND AIMS: Postoperative recurrence of Crohn's disease [POR-CD] is almost certain if no prophylaxis is administered. …
Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
Gjuladin-Hellon T, Iheozor-Ejiofor Z, Gordon M, Akobeng AK. Gjuladin-Hellon T, et al. Cochrane Database Syst Rev. 2019 Aug 6;8(8):CD010233. doi: 10.1002/14651858.CD010233.pub3. Cochrane Database Syst Rev. 2019. PMID: 31425621 Free PMC article.
BACKGROUND: Crohn's disease (CD) is a chronic relapsing inflammatory condition and maintenance of remission is a major issue as many patients fail to achieve remission with medical management and require surgical interventions. Purine analogues such as azathiopri
BACKGROUND: Crohn's disease (CD) is a chronic relapsing inflammatory condition and maintenance of remission is a major issue a …
[Azathioprine in Crohn's disease therapy--guidance against the background of recent studies].
Schmidt C, Herrlinger K, Siegmund B, Bokemeyer B, Schreiber S, Stallmach A; Kompetenznetz Darmerkrankungen. Schmidt C, et al. Z Gastroenterol. 2014 Dec;52(12):1423-30. doi: 10.1055/s-0034-1385650. Epub 2014 Dec 4. Z Gastroenterol. 2014. PMID: 25474282 Review. German.
Thiopurines (azathioprine and 6-mercaptopurine) are the most frequently used drugs in the treatment of patients with Crohn's disease. ...Therefore, in this survey recently published data are discussed on the background of our knowledge on the efficacy of a
Thiopurines (azathioprine and 6-mercaptopurine) are the most frequently used drugs in the treatment of patients with Crohn's …
Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA.
Haveran LA, Sehgal R, Poritz LS, McKenna KJ, Stewart DB, Koltun WA. Haveran LA, et al. Dis Colon Rectum. 2011 Jan;54(1):15-20. doi: 10.1007/DCR.0b013e3181fc9f04. Dis Colon Rectum. 2011. PMID: 21160308
METHODS: We conducted a retrospective chart review of all patients who underwent IPAA who experienced Crohn's disease-like complications (pouch fistulas, stricturing small-bowel disease, or pouchitis unresponsive to antibiotics) after ileostomy closure. ...RE …
METHODS: We conducted a retrospective chart review of all patients who underwent IPAA who experienced Crohn's disease-like com …
Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
Magro F, Santos-Antunes J, Vilas-Boas F, Rodrigues-Pinto E, Coelho R, Ribeiro OS, Lopes S, Macedo G. Magro F, et al. J Crohns Colitis. 2014 Jul;8(7):617-25. doi: 10.1016/j.crohns.2013.11.020. Epub 2013 Dec 12. J Crohns Colitis. 2014. PMID: 24332869
BACKGROUND AND AIMS: Azathioprine is of major importance in the treatment of Crohn's disease; its efficacy has been showed in several works, but real-life data regarding its use is scarce. Our aim was to address the outcome of patients with Crohn's …
BACKGROUND AND AIMS: Azathioprine is of major importance in the treatment of Crohn's disease; its efficacy has been sho …
Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.
Boyapati RK, Torres J, Palmela C, Parker CE, Silverberg OM, Upadhyaya SD, Nguyen TM, Colombel JF. Boyapati RK, et al. Cochrane Database Syst Rev. 2018 May 12;5(5):CD012540. doi: 10.1002/14651858.CD012540.pub2. Cochrane Database Syst Rev. 2018. PMID: 29756637 Free PMC article. Review.
BACKGROUND: Crohn's disease (CD) is a chronic, relapsing and remitting disease of the gastrointestinal tract that can cause significant morbidity and disability. ...AUTHORS' CONCLUSIONS: The effects of withdrawal of immunosuppressant therapy in people with qu …
BACKGROUND: Crohn's disease (CD) is a chronic, relapsing and remitting disease of the gastrointestinal tract that can c …
Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis.
Pearson DC, May GR, Fick GH, Sutherland LR. Pearson DC, et al. Ann Intern Med. 1995 Jul 15;123(2):132-42. doi: 10.7326/0003-4819-123-2-199507150-00009. Ann Intern Med. 1995. PMID: 7778826
PURPOSE: To assess the effectiveness of azathioprine and 6-mercaptopurine in inducing remission of active Crohn disease and the effectiveness of azathioprine in maintaining remission of quiescent disease. ...DATA SYNTHESIS: Compared with placebo …
PURPOSE: To assess the effectiveness of azathioprine and 6-mercaptopurine in inducing remission of active Crohn disease
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M. Prefontaine E, et al. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000067. doi: 10.1002/14651858.CD000067.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160175 Updated. Review.
OBJECTIVES: To assess the efficacy of azathioprine and 6-mercaptopurine for maintenance of remission in quiescent Crohn's disease. ...AUTHORS' CONCLUSIONS: Azathioprine and 6-mercaptopurine are more effective than placebo for maintenance of remission i …
OBJECTIVES: To assess the efficacy of azathioprine and 6-mercaptopurine for maintenance of remission in quiescent Crohn's d
2,325 results
Jump to page
Feedback